NCT03308383

Brief Summary

Echocardiography forms one of the most used modality in the evaluation of cardiac anatomy and functions in both patients with cardiac symptoms and in healthy individuals for occupational and research purpose. The interpretation of any medical investigation including echocardiographic report is based on its comparison with the normal range for that parameter, which is known to vary depending on the age, sex, body surface area (BSA), ethnicity and race. Since most of the medical/surgical treatment decisions are made based on the echocardiographic reports, the interpretation of results should be accurate. Even though there are many studies defining reference ranges of echocardiographic parameters, most of them were based on studies conducted in Western and European population, who shows considerable difference in their anthropometric measurements from the Indian population. Hence for the accurate diagnosis of any cardiac abnormalities, the reference values should have been derived from studies conducted in population of that particular race and ethnicity who are free of risk factors for the cardiac disease. Hence the investigator planned to conduct a study to determine the normal Echocardiographic parameters and compare it with the reference range of established by American society of echocardiography (ASE).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable healthy

Timeline
Completed

Started Jan 2018

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 27, 2017

Completed
15 days until next milestone

First Posted

Study publicly available on registry

October 12, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

January 1, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2018

Completed
Last Updated

January 17, 2018

Status Verified

January 1, 2018

Enrollment Period

6 months

First QC Date

September 27, 2017

Last Update Submit

January 12, 2018

Conditions

Outcome Measures

Primary Outcomes (14)

  • EDLVID

    End diastole left ventricle internal diameter

    up to 30 minutes

  • ESLVID

    End systole left ventricle internal diameter

    up to 30 minutes

  • EDIVST

    End diastole inter-ventricular septum thickness

    up to 30 minutes

  • ESIVST

    End systole inter-ventricular septum thickness

    up to 30 minutes

  • EDPWT

    End diastole posterior wall thickness

    up to 30 minutes

  • ESPWT

    End systole posterior wall thickness

    up to 30 minutes

  • LVEF

    Left ventricle ejection fraction

    up to 30 minutes

  • LV strain

    Left ventricle strain

    up to 30 minutes

  • TAPSE

    Tricuspid annular plane systolic excursion

    up to 30 minutes

  • RV FAC

    Right ventricle fractional area change

    up to 30 minutes

  • RV TEI index

    Right ventricle TEI index

    up to 30 minutes

  • Mitral and tricuspid E',A', S'

    Mitral and tricuspid annular tissue velocities

    up to 30 minutes

  • RVOT diameter

    Right ventricle outflow tract diameter

    up to 30 minutes

  • Mitral tricuspid aortic pulmonary annulus diameter

    Mitral tricuspid aortic pulmonary annulus diameter

    up to 30 minutes

Study Arms (1)

TRANSTHORACIC ECHOCARDIOGRAM

EXPERIMENTAL

Individuals who visit pre-anaesthetic check up (PAC) clinic for minor surgery which includes plastic, rhino-otolaryngeal, ophthalmologic, orthopaedic, abdominal, urological, gynaecological surgeries, who are free of cardiac disease or any known risk factors for the cardiac disease like chronic alcoholism, chronic smoking, metabolic syndrome, morbid obesity

Other: DOING TRANSTHORACIC ECHOCARDIOGRAM

Interventions

TRANSTHORACIC ECHOCARDIOGRAM WILL BE DONE IN THE PARTICIPANTS WHICH IS NON-INVASIVE

TRANSTHORACIC ECHOCARDIOGRAM

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • \- Age between18 to 60 years

You may not qualify if:

  • History of congenital or acquired cardiac abnormality
  • Symptoms and Signs suggestive of any cardio-respiratory disease
  • Systemic hypertension SBP more than 140 and DBP more than90
  • Known case of Diabetes mellitus or signs and symptoms suggesting like polyuria, polydipsia, autonomic dysfunction
  • History of long term exercise
  • Systemic disease like chronic kidney disease, chronic liver disease, chronic obstructive pulmonary disease
  • LVH or any abnormality in ECG
  • Abnormal chest X-ray
  • Obesity defined by BMI MORE THAN 25 kg/m2)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

PGIMER

Chandigarh, 160012, India

RECRUITING

PGIMER

Chandigarh, 160012, India

RECRUITING

Study Officials

  • GANESH KUMAR, MD

    PGIMER, CHANDIGARH, INDIA

    PRINCIPAL INVESTIGATOR

Central Study Contacts

GANESH KUMAR, MD

CONTACT

GOVERDHAN D PURI, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 27, 2017

First Posted

October 12, 2017

Study Start

January 1, 2018

Primary Completion

June 30, 2018

Study Completion

June 30, 2018

Last Updated

January 17, 2018

Record last verified: 2018-01

Data Sharing

IPD Sharing
Will not share

Locations